The government plans to help boost the local small-molecule drug CDMO industry by cooperating with firms to jointly develop key technology platforms, the Ministry of Economic Affairs (MOEA) said yesterday.
CDMO refers to a contract development and manufacturing organization, which provides essential services to both pharmaceutical and biotech companies with lower-cost, time-saving drug research, manufacturing and testing processes.
The key technology platforms, which would have a high entry threshold, include active pharmaceutical ingredient (API) intermediates, continuous manufacturing processes as well as special delivery solutions and dosage forms for small molecules, the ministry said in a statement.
Photo courtesy of Ministry of Economic Affairs
The ministry said it would also assist firms in conducting carbon emission investigations, enhance their engagement in international markets and simplify administrative procedures to facilitate global CDMO business opportunities.
The ministry’s remarks came after it held a meeting on Wednesday with representatives from domestic API makers, pharmaceutical formulation providers and
medical associations, as well as several health and welfare officials and researchers to discuss how to promote Taiwan’s small molecule CDMO industry.
Small molecule drugs are synthesized organic compounds with low molecular weights that allow them to penetrate cells easily and target important proteins.
The production value of small molecule drugs accounts for about 70 percent of Taiwan’s total pharmaceutical output of NT$108.9 billion (US$3.5 billion), making it a key part of the nation’s pharmaceutical industry, the ministry said.
However, many local small molecule drug manufacturers are less focused on advanced technology and lack connections with international markets, the ministry said, adding that it aims to help fims upgrade and build international links.
Rising demand for small molecule drugs is expected to create business opportunities for CDMOs. A Future Market Insights report issued in November last year said that the global small molecule CDMO market is projected to be valued at about US$124.53 billion in 2034, as the market is estimated to grow at a compound annual growth rate of 5.24 percent over the next 10 years.
To many, Tatu City on the outskirts of Nairobi looks like a success. The first city entirely built by a private company to be operational in east Africa, with about 25,000 people living and working there, it accounts for about two-thirds of all foreign investment in Kenya. Its low-tax status has attracted more than 100 businesses including Heineken, coffee brand Dormans, and the biggest call-center and cold-chain transport firms in the region. However, to some local politicians, Tatu City has looked more like a target for extortion. A parade of governors have demanded land worth millions of dollars in exchange
An Indonesian animated movie is smashing regional box office records and could be set for wider success as it prepares to open beyond the Southeast Asian archipelago’s silver screens. Jumbo — a film based on the adventures of main character, Don, a large orphaned Indonesian boy facing bullying at school — last month became the highest-grossing Southeast Asian animated film, raking in more than US$8 million. Released at the end of March to coincide with the Eid holidays after the Islamic fasting month of Ramadan, the movie has hit 8 million ticket sales, the third-highest in Indonesian cinema history, Film
Taiwan Semiconductor Manufacturing Co’s (TSMC, 台積電) revenue jumped 48 percent last month, underscoring how electronics firms scrambled to acquire essential components before global tariffs took effect. The main chipmaker for Apple Inc and Nvidia Corp reported monthly sales of NT$349.6 billion (US$11.6 billion). That compares with the average analysts’ estimate for a 38 percent rise in second-quarter revenue. US President Donald Trump’s trade war is prompting economists to retool GDP forecasts worldwide, casting doubt over the outlook for everything from iPhone demand to computing and datacenter construction. However, TSMC — a barometer for global tech spending given its central role in the
Alchip Technologies Ltd (世芯), an application-specific integrated circuit (ASIC) designer specializing in server chips, expects revenue to decline this year due to sagging demand for 5-nanometer artificial intelligence (AI) chips from a North America-based major customer, a company executive said yesterday. That would be the first contraction in revenue for Alchip as it has been enjoying strong revenue growth over the past few years, benefiting from cloud-service providers’ moves to reduce dependence on Nvidia Corp’s expensive AI chips by building their own AI accelerator by outsourcing chip design. The 5-nanometer chip was supposed to be a new growth engine as the lifecycle
RSS